Il y a eu 50 transactions d'initiés récentes enregistrées pour The Pennant Group, Inc. (PNTG), dont 37 achats et 7 ventes. Le total des achats d'initiés s'élève à $5.86M et le total des ventes d'initiés à $423.74K.
Les initiés notables ayant une activité récente comprennent Cheney Kirk Sterling, Steik Jason Paul, Gochnour John J. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — PNTG
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-05-16 |
Cheney Kirk Sterling |
EVP, Gc and Corp Secy |
Inconnu |
35,000 |
$30.22 |
$1.06M |
- |
| 2026-05-16 |
Steik Jason Paul |
Chief Clinical Officer |
Inconnu |
35,000 |
$30.22 |
$1.06M |
- |
| 2026-03-05 |
Gochnour John J |
Chief Operating Officer |
Attribution de RSU |
41,000 |
$33.30 |
$1.37M |
41,000 |
| 2026-03-05 |
Guerisoli Brent |
Chief Executive Officer |
Attribution de RSU |
45,000 |
$33.30 |
$1.5M |
45,000 |
| 2026-03-05 |
Walbom Lynette |
Chief Financial Officer |
Attribution de RSU |
34,000 |
$33.30 |
$1.13M |
34,000 |
| 2026-03-05 |
Steik Jason Paul |
Chief Clinical Officer |
Attribution de RSU |
26,000 |
$33.30 |
$865.8K |
26,000 |
| 2026-03-05 |
Cheney Kirk Sterling |
EVP, Gc and Corp Secy |
Attribution de RSU |
30,000 |
$33.30 |
$999K |
30,000 |
| 2026-03-03 |
Gochnour John J |
Chief Operating Officer |
Attribution de RSU |
18,565 |
- |
- |
152,815 |
| 2026-03-03 |
Guerisoli Brent |
Chief Executive Officer |
Attribution de RSU |
20,052 |
- |
- |
102,030 |
| 2026-03-03 |
Walbom Lynette |
Chief Financial Officer |
Attribution de RSU |
14,292 |
- |
- |
16,955 |
| 2026-03-03 |
Cheney Kirk Sterling |
EVP, Gc and Corp Secy |
Attribution de RSU |
4,085 |
- |
- |
21,005 |
| 2026-01-15 |
Covey Stephen M R |
Director |
Attribution de RSU |
1,900 |
- |
- |
40,250 |
| 2026-01-15 |
Smith Barry M |
Director |
Attribution de RSU |
1,900 |
- |
- |
98,699 |
| 2026-01-15 |
Lamb Scott E |
Director |
Attribution de RSU |
2,400 |
- |
- |
54,135 |
| 2026-01-15 |
Christensen Christopher R. |
Director |
Attribution de RSU |
1,900 |
- |
- |
142,191 |
| 2026-01-15 |
Nackel John G. |
Director |
Attribution de RSU |
1,900 |
- |
- |
170,765 |
| 2026-01-15 |
Snapper Suzanne D. |
Director |
Attribution de RSU |
1,900 |
- |
- |
226,564 |
| 2026-01-15 |
Morris Gregory K Sr. |
Director |
Attribution de RSU |
1,900 |
- |
- |
33,500 |
| 2025-11-11 |
Cheney Kirk Sterling |
EVP, Gc and Corp Secy |
Exercice d'Options (Vente) |
3,800 |
$15.09 |
$57.34K |
4,200 |
| 2025-10-15 |
Covey Stephen M R |
Director |
Attribution de RSU |
1,900 |
- |
- |
38,350 |
| 2025-10-15 |
Smith Barry M |
Director |
Attribution de RSU |
1,900 |
- |
- |
96,799 |
| 2025-10-15 |
Lamb Scott E |
Director |
Attribution de RSU |
2,400 |
- |
- |
51,735 |
| 2025-10-15 |
Christensen Christopher R. |
Director |
Attribution de RSU |
1,900 |
- |
- |
140,291 |
| 2025-10-15 |
Nackel John G. |
Director |
Attribution de RSU |
1,900 |
- |
- |
168,865 |
| 2025-10-15 |
Snapper Suzanne D. |
Director |
Attribution de RSU |
1,900 |
- |
- |
224,664 |
| 2025-10-15 |
Morris Gregory K Sr. |
Director |
Attribution de RSU |
1,900 |
- |
- |
31,600 |
| 2025-10-09 |
Smith Barry M |
Director |
Exercice d'Options (Vente) |
10,000 |
$11.35 |
$113.5K |
10,000 |
| 2025-07-28 |
Cheney Kirk Sterling |
EVP, Gc and Corp Secy |
Vente Informative |
880 |
$23.34 |
$20.54K |
13,120 |
| 2025-07-28 |
Guerisoli Brent |
Chief Executive Officer |
Vente Informative |
3,995 |
$23.34 |
$93.23K |
81,978 |
| 2025-07-15 |
Covey Stephen M R |
Director |
Attribution de RSU |
1,900 |
- |
- |
36,450 |
| 2025-07-15 |
Smith Barry M |
Director |
Attribution de RSU |
1,900 |
- |
- |
84,899 |
| 2025-07-15 |
Lamb Scott E |
Director |
Attribution de RSU |
2,400 |
- |
- |
49,335 |
| 2025-07-15 |
Christensen Christopher R. |
Director |
Attribution de RSU |
1,900 |
- |
- |
138,391 |
| 2025-07-15 |
Nackel John G. |
Director |
Attribution de RSU |
1,900 |
- |
- |
166,965 |
| 2025-07-15 |
Snapper Suzanne D. |
Director |
Attribution de RSU |
1,900 |
- |
- |
222,764 |
| 2025-07-15 |
Morris Gregory K Sr. |
Director |
Attribution de RSU |
1,900 |
- |
- |
29,700 |
| 2025-05-20 |
Stringfield Joanne |
Director |
Exercice d'Options (Vente) |
5,000 |
$15.09 |
$75.45K |
- |
| 2025-05-16 |
Snapper Suzanne D. |
Director |
Inconnu |
- |
- |
- |
220,864 |
| 2025-05-01 |
Stringfield Joanne |
Director |
Vente Informative |
665 |
$25.62 |
$17.04K |
30,275 |
| 2025-04-29 |
Gochnour John J |
Chief Operating Officer |
Exercice d'Options (Vente) |
6,286 |
$7.42 |
$46.64K |
- |
| 2025-04-17 |
Cheney Kirk Sterling |
EVP, Gc and Corp Secy |
Inconnu |
- |
- |
- |
14,000 |
| 2025-04-17 |
Steik Jason Paul |
Chief Clinical Officer |
Inconnu |
- |
- |
- |
647 |
| 2025-04-15 |
Covey Stephen M R |
Director |
Attribution de RSU |
1,900 |
- |
- |
34,550 |
| 2025-04-15 |
Smith Barry M |
Director |
Attribution de RSU |
1,900 |
- |
- |
82,999 |
| 2025-04-15 |
Lamb Scott E |
Director |
Attribution de RSU |
2,400 |
- |
- |
46,935 |
| 2025-04-15 |
Christensen Christopher R. |
Director |
Attribution de RSU |
1,900 |
- |
- |
136,491 |
| 2025-04-15 |
Nackel John G. |
Director |
Attribution de RSU |
1,900 |
- |
- |
165,065 |
| 2025-04-15 |
Stringfield Joanne |
Director |
Attribution de RSU |
1,900 |
- |
- |
30,940 |
| 2025-04-15 |
Morris Gregory K Sr. |
Director |
Attribution de RSU |
1,900 |
- |
- |
27,800 |
| 2025-03-04 |
Cheney Kirk Sterling |
EVP, Gc and Corp Secy |
Inconnu |
20,000 |
$18.79 |
$375.8K |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
